Patents by Inventor Antony Wilkes Burgess

Antony Wilkes Burgess has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Truncated EGF receptor
    Patent number: 7449559
    Abstract: The present invention relates to truncated EGF receptor molecules that exhibit increased binding affinities for EGFR ligands such as EGF and TGF1. The present invention also relates to methods of screening for EGF receptor ligands and methods of treatment which involve the use of these molecules.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: November 11, 2008
    Assignees: Commonwealth Scientific and Industrial Research Organisation, Ludwig Insitutute for Cancer Research
    Inventors: Colin Wesley Ward, Neil Moreton McKern, George Oscar Lovrecz, Robert Nicholas Jorissen, Thomas Peter John Garrett, Thomas Charles Elleman, Antony Wilkes Burgess, Timothy Edward Adams, Teresa Anne Domagala, Edouard Collins Nice
  • Truncated EGF receptor
    Patent number: 6946543
    Abstract: The present invention relates to truncated EGF receptor molecules that exhibit increased binding affinities for EGFR ligands such as EGF and TGF-?. The present invention also relates to methods of screening for EGF receptor ligands and methods of treatment which involve the use of these molecules.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: September 20, 2005
    Assignees: Commonwealth Scientific and Industrial Research Organisation, Ludwig Institute for Cancer Research
    Inventors: Colin Wesley Ward, Neil Morton McKern, George Oscar Lovrecz, Robert Nicholas Jorissen, Thomas Peter John Garrett, Thomas Charles Elleman, Antony Wilkes Burgess, Timothy Edward Adams, Teresa Anne Domagala, Edouard Nice